We are live on ! Find out more
TTP

TITAN PHARMACEUTICAL INC
TTP

Delisted

TTP was delisted on the 24th of December, 2008.

Back to rankings

3 hedge funds and large institutions have $508K invested in TITAN PHARMACEUTICAL INC in 2014 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more capital invested

Capital invested by funds: $332K → $508K (+$176K)

0% more funds holding

Funds holding: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JIR
James Investment Research
Ohio
+$137K

Top Sellers

Rank Fund Capital Flow
1
GS
Gagnon Securities
New York
-$14.9K
2
HRIA
Haberer Registered Investment Advisor
Ohio
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
GS
1
Gagnon Securities
New York
$370K -$14.9K -18,973 -4%
JIR
2
James Investment Research
Ohio
$137K +$137K +174,140 New
ECM
3
Estabrook Capital Management
New York
$784 – – –
HRIA
4
Haberer Registered Investment Advisor
Ohio
– -$2K -2,850 Closed

TTP Hedge Fund Activity: Q2 2014 in Review

3 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in TITAN PHARMACEUTICAL INC (TTP) for Q2 2014, worth a combined $508K — up 53% from $332K a quarter earlier.

Fund positioning in TTP was balanced in Q2 2014: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was James Investment Research, opening a new position worth an estimated $137K. The largest seller was Gagnon Securities, cutting an estimated $14.9K.

  • 3 institutional investors held TITAN PHARMACEUTICAL INC (TTP) as of Q2 2014, unchanged from Q1 2014.
  • Funds reported $508K of TITAN PHARMACEUTICAL INC stock for Q2 2014, up 53% quarter-over-quarter.
  • 1 fund opened new TITAN PHARMACEUTICAL INC positions in Q2 2014 and 1 closed out, a net change of 0 holders.
  • The largest TITAN PHARMACEUTICAL INC buyer in Q2 2014 was James Investment Research, an estimated $137K added.
  • The largest TITAN PHARMACEUTICAL INC seller in Q2 2014 was Gagnon Securities, an estimated $14.9K sold.

Based on aggregated 13F filings for Q2 2014.